Past EventMajor Advances In Cancer Therapeutics

Speaker:  Jerome Brimeyer, CIO Wealth Management Researchfor UBS Financial Services

Join us on Wednesday, September 17th, to learn about the current cancer treatments and new targeted therapies being developed for various cancers plus potential acquisitions that larger players might be making to obtain blockbuster therapeutics they need.

 Speaker Bio:  Jerry Brimeyer joined UBS Wealth Management Research as a healthcare analyst in 2009.  His career began as a healthcare equity analyst at National City Bank in Cleveland, Ohio where he was responsible for coverage of U.S. healthcare stocks.  From there he moved to New York, mostly covering U.S. pharmaceutical companies for Dean Witter, Kidder Peabody, Lehman Brothers and UBS Securities.  While at Lehman Jerry was the #1-ranked Pharmaceutical Analyst by Institutional Investor for four consecutive years.  Subsequently he became the Global Sector Coordinator for Pharmaceutical and Healthcare Research at UBS Investment Bank, a role for which he relocated to London.  In 2005 he joined Dresdner Kleinwort in London as a Senior Equity Analyst covering U.S. and European pharmaceutical companies, prior to relocating to New York.

Share:
Novo Norodisk

Novo Norodisk

Southwest Labs

Southwest Labs